Can Ozempic end addiction? | Dhruv Khullar | Your Body on Tech
Oct 9, 2026 · 47m
Summary
In this TED Tech episode, host Manoush Zomorodi introduces a special series on how technology reshapes human biology, featuring physician Dhruv Kular. Kular discusses the emerging science of GLP-1 medications, explaining how they act as "moderation molecules" that blunt dopamine spikes to treat addictions like alcoholism and gambling. The conversation explores the neurobiological basis of addiction, the potential for these drugs to reduce stigma, and the ethical challenges of using powerful medical interventions to combat modern excess and distraction.
Topics discussed
Introduction to the TED Tech series and show
Preview of Dhruv Kular's talk on GLP-1s and addiction
Sponsor segments for Schwab, Rolex, and LA28
Case study: Mary's experience with Ozempic and alcohol
History of GLP-1 discovery via Komodo dragon venom
Research on GLP-1s and various addiction types
Mechanism: Dopamine modulation and reward pathways
Limitations: Tolerance and the need for moderation
The unpredictability of medical innovation
Aristotle's moderation in the age of digital distraction
Personal anecdotes from emergency room medicine
Sponsor segment for Parloa AI
Interview: Mary's weight loss and sobriety maintenance
Interview: Evidence for GLP-1s in addiction treatment
Interview: The role of dopamine and brain mysteries
Interview: Gut-brain axis and receptor distribution
Sponsor segments for Creighton and Perk
Interview: Shifting blame from character to biology
Interview: Broad health benefits beyond weight loss
Interview: Adherence, cost, and side effects
Interview: Muscle preservation and long-term safety
Interview: Preventive use in children and adolescents
Interview: Addressing root causes of health epidemics
Interview: Unregulated use and cultural phenomena
Interview: Future medication options and medicine as tech
Interview: Patient autonomy and the need for evidence
Interview: The changing patient-physician relationship
Interview: The high failure rate of drug development
Interview: Personal agency and environmental harmony
Interview: Final advice on cautious use
Host reflection on skepticism and the peptide craze
Credits and preview of the next episode
Closing remarks and sponsor segment for Perk
Sponsor segment for ServiceNow
Listen ad-free on Castria